Pennsylvania lawmakers react to Trump reclassifying marijuana as a Schedule III drug

President Trump signed an executive order rescheduling marijuana from a Schedule I to a Schedule III drug, a move Pennsylvania lawmakers say will bolster medical cannabis research and the existing medical marijuana marketplace and give political cover to Republicans considering adult-use legalization. State legislators including Democrats Emily Kinkead and Dan Frankel — and Republican co-sponsor Abby Major — say the change increases the likelihood of passing a legal adult-use cannabis market in Pennsylvania, potentially by 2026, but emphasize state legislation is still required and federal agencies will need time to implement the change. Federal Republican opposition cited health and safety concerns, underscoring ongoing political and regulatory steps before market effects fully materialize.

Analysis

Market structure: Rescheduling to Schedule III materially reduces federal criminal risk and should accelerate institutional capital flow into U.S. multi-state operators (MSOs) and cannabis REITs (IIPR). Expect a re-rating of MSCI-style cannabis ETFs (MJ, MSOS) and large MSOs (CURLF, CRLBF, GTBIF) over 6–24 months as state rollouts (PA targeted 2026) expand addressable market; wholesale flower prices could face 10–30% downward pressure in newly legal states as supply responds over 12–18 months.

Risk assessment: Main tail risks are federal reversal or legal challenges, slow DEA/DEA successor implementation (0–90 days bureaucratic lag), and state-level high excise taxes or licensing caps that sustain black-market share. Near-term (days–weeks) expect headline-driven volatility; medium-term (3–12 months) depends on banking guidance (OCC/FDIC) and IRS/SEC clarity on taxation and reporting; long-term (2–5 years) outcome hinges on nationwide banking access and interstate commerce rules.

Trade implications: Favor liquid, diversified plays (MJ/MSOS ETFs) and vertically integrated U.S. MSOs with retail scale and balance-sheet discipline (CURLF, CRLBF, GTBIF) plus IIPR for property exposure; avoid leverage-heavy, loss-making Canadian LPs (CGC, TLRY) that remain oversupplied. Use calendar spread and LEAP call spreads to own upside while capping carry; reduce alcohol/beer exposure modestly (1–2% reallocation) over 12–24 months to capture secular substitution.

Contrarian angles: Consensus assumes instant banking normalization and tax parity — that is likely underdone; expect fragmented state regimes, persistent high banking/compliance costs, and supplemental state taxes that compress margins ~200–600 bps vs. consumer staples. A profitable, disciplined MSO that can maintain EBITDA margins >18% in legalized states will be scarce and likely outperform; conversely, names betting only on federal relief without state-level distribution are mispriced short candidates.

Key Decisions for Investors

• Establish a 2–3% long position in ETF MJ or MSOS within 2–6 weeks to capture sector re-rating, add another 1–2% if DOJ/DEA issues formal guidance within 90 days.
• Initiate 1–2% long positions in two U.S. MSOs: CURLF and GTBIF (1% each), focusing on companies with positive EBITDA or clear path to positive FCF; scale into 3–6% cumulative exposure if quarterly same-store sales grow >5% QoQ for two consecutive quarters.
• Buy a 9–15 month call spread on IIPR (e.g., buy 12–15% OTM LEAP call, sell 30% OTM) sized to 1–2% notional to play real-estate upside while limiting premium risk; close if implied vol spikes >40% or FFO guidance misses by >10%.
• Short/underweight Canadian LPs (CGC, TLRY) or high-burn U.S. juniors via CDS or put spreads (target 2–4% portfolio risk) — add if headline volume fails to translate to retail margin expansion within 12 months or if wholesale prices decline >20%.
• Monitor three catalysts on a 30–90 day cadence: (1) DEA/DOJ rule language and effective date, (2) OCC/FDIC banking guidance for cannabis clients, (3) Pennsylvania legislative calendar for adult-use votes. Increase position sizes only after two catalysts confirm (banking clarity + state bill progress).